311 related articles for article (PubMed ID: 26934324)
1. Role of multifaceted regulators in cancer glucose metabolism and their clinical significance.
Zhao L; Mao Y; Zhao Y; Cao Y; Chen X
Oncotarget; 2016 May; 7(21):31572-85. PubMed ID: 26934324
[TBL] [Abstract][Full Text] [Related]
2. Two p53-related metabolic regulators, TIGAR and SCO2, contribute to oroxylin A-mediated glucose metabolism in human hepatoma HepG2 cells.
Dai Q; Yin Y; Liu W; Wei L; Zhou Y; Li Z; You Q; Lu N; Guo Q
Int J Biochem Cell Biol; 2013 Jul; 45(7):1468-78. PubMed ID: 23612020
[TBL] [Abstract][Full Text] [Related]
3. Acetylation mediated by the p300/CBP-associated factor determines cellular energy metabolic pathways in cancer.
Rajendran R; Garva R; Ashour H; Leung T; Stratford I; Krstic-Demonacos M; Demonacos C
Int J Oncol; 2013 Jun; 42(6):1961-72. PubMed ID: 23591450
[TBL] [Abstract][Full Text] [Related]
4. Non-coding RNAs in the reprogramming of glucose metabolism in cancer.
Shankaraiah RC; Veronese A; Sabbioni S; Negrini M
Cancer Lett; 2018 Apr; 419():167-174. PubMed ID: 29366802
[TBL] [Abstract][Full Text] [Related]
5. Regulation of glucose metabolism by p53: emerging new roles for the tumor suppressor.
Madan E; Gogna R; Bhatt M; Pati U; Kuppusamy P; Mahdi AA
Oncotarget; 2011 Dec; 2(12):948-57. PubMed ID: 22248668
[TBL] [Abstract][Full Text] [Related]
6. KRAB-type zinc-finger proteins PITA and PISA specifically regulate p53-dependent glycolysis and mitochondrial respiration.
Wang S; Peng Z; Wang S; Yang L; Chen Y; Kong X; Song S; Pei P; Tian C; Yan H; Ding P; Hu W; Liu CH; Zhang X; He F; Zhang L
Cell Res; 2018 May; 28(5):572-592. PubMed ID: 29467382
[TBL] [Abstract][Full Text] [Related]
7. TIGAR, a p53-inducible regulator of glycolysis and apoptosis.
Bensaad K; Tsuruta A; Selak MA; Vidal MN; Nakano K; Bartrons R; Gottlieb E; Vousden KH
Cell; 2006 Jul; 126(1):107-20. PubMed ID: 16839880
[TBL] [Abstract][Full Text] [Related]
8. Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer.
Yeung SJ; Pan J; Lee MH
Cell Mol Life Sci; 2008 Dec; 65(24):3981-99. PubMed ID: 18766298
[TBL] [Abstract][Full Text] [Related]
9. Cancer cell metabolism and developmental homeodomain/POU domain transcription factors: a connecting link.
Purkayastha BP; Roy JK
Cancer Lett; 2015 Jan; 356(2 Pt A):315-9. PubMed ID: 24909495
[TBL] [Abstract][Full Text] [Related]
10. The pivotal role of MicroRNAs in glucose metabolism in cancer.
Taefehshokr S; Taefehshokr N; Hemmat N; Hajazimian S; Isazadeh A; Dadebighlu P; Baradaran B
Pathol Res Pract; 2021 Jan; 217():153314. PubMed ID: 33341548
[TBL] [Abstract][Full Text] [Related]
11. MYC-induced cancer cell energy metabolism and therapeutic opportunities.
Dang CV; Le A; Gao P
Clin Cancer Res; 2009 Nov; 15(21):6479-83. PubMed ID: 19861459
[TBL] [Abstract][Full Text] [Related]
12. Distinctive interrelation of p53 with SCO2, COX, and TIGAR in human gastric cancer.
Kim SH; Choi SI; Won KY; Lim SJ
Pathol Res Pract; 2016 Oct; 212(10):904-910. PubMed ID: 27499152
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function.
Rajeshkumar NV; Dutta P; Yabuuchi S; de Wilde RF; Martinez GV; Le A; Kamphorst JJ; Rabinowitz JD; Jain SK; Hidalgo M; Dang CV; Gillies RJ; Maitra A
Cancer Res; 2015 Aug; 75(16):3355-64. PubMed ID: 26113084
[TBL] [Abstract][Full Text] [Related]
14. Glucose metabolism and cancer.
Shaw RJ
Curr Opin Cell Biol; 2006 Dec; 18(6):598-608. PubMed ID: 17046224
[TBL] [Abstract][Full Text] [Related]
15. Metabolic phenotype of bladder cancer.
Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
[TBL] [Abstract][Full Text] [Related]
16. miR-101 Enhances Cisplatin-Induced DNA Damage Through Decreasing Nicotinamide Adenine Dinucleotide Phosphate Levels by Directly Repressing Tp53-Induced Glycolysis and Apoptosis Regulator Expression in Prostate Cancer Cells.
Huang S; Yang Z; Ma Y; Yang Y; Wang S
DNA Cell Biol; 2017 Apr; 36(4):303-310. PubMed ID: 28384067
[TBL] [Abstract][Full Text] [Related]
17. Regulation of cancer cell metabolism by hypoxia-inducible factor 1.
Semenza GL
Semin Cancer Biol; 2009 Feb; 19(1):12-6. PubMed ID: 19114105
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of energy metabolism-related, p53-target TIGAR and SCO2 in HuH-7 cells with p53 mutation by geranylgeranoic acid treatment.
Iwao C; Shidoji Y
Biomed Res; 2015; 36(6):371-81. PubMed ID: 26700591
[TBL] [Abstract][Full Text] [Related]
19. Selective anti-tumor activity of wogonin targeting the Warburg effect through stablizing p53.
Zhao Y; Zhang L; Wu Y; Dai Q; Zhou Y; Li Z; Yang L; Guo Q; Lu N
Pharmacol Res; 2018 Sep; 135():49-59. PubMed ID: 30031170
[TBL] [Abstract][Full Text] [Related]
20. p53 and glucose metabolism: an orchestra to be directed in cancer therapy.
Gomes AS; Ramos H; Soares J; Saraiva L
Pharmacol Res; 2018 May; 131():75-86. PubMed ID: 29580896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
